Learn More
Medchemexpress LLC (11-((4-hydroxy-3-methoxybenzoyl)oxy)undecyl)triphenylphosphonium bromide | 1254044-38-6 | 99.8% | 663.62 | C37H44BrO4P | 5 MG

Supplier: Medchemexpress LLC HY1358695MG
Mito-apocynin (C11) is an orally active, mitochondria-targeted apocynin derivative in which the apocynin moiety is conjugated to a triphenylphosphonium (TPP+) group to selectively deliver antioxidant activity to mitochondria. It is supplied for research use and has shown neuroprotective effects in preclinical oral dosing studies, with reported improvements in olfaction and motor coordination.
- Mitochondria-targeted antioxidant delivered via TPP+ conjugation.
- Demonstrated neuroprotective effects in preclinical models.
- Orally active, suitable for in vivo dosing studies.
- High supplied purity for experimental consistency.
- Available in multiple small pack sizes for dosing flexibility.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.